Clears the way to finalize Phase 3 protocol and recruit sites for U.S. Phase 3 substantially funded by $17.0 million CPRIT grant and $8.5 million Company match Biodexa Pharmaceuticals PLC (“Biodexa” ...
Quotient Sciences has successfully initiated a clinical study evaluating a novel drug product developed using AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results